A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. This year’s metric has recorded a Price increase of 47.08%. However, over the past six months, we’ve
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Year to date metric has recorded a gain of 41.42%.However, over the last six months, we can
Monte Rosa Therapeutics Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $8.84 on 03/26/24, while the lowest price for the same duration was marked at $2.44 on 10/27/23. 52-week price history of GLUE
All rights reserved © 2024, Powered By Smart TechOne
